Product Information

BRIVIACT 100 MG TABLET is a brand product labeled by UCB, Inc., priced at $24.0762 per EA under NDC 50474077066. Its NADAC has been published 479 times since Jun 21, 2017.

FDA first approved this application on May 12, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BRIVIACT 100 MG TABLET

brivaracetam
$24.0762per EA
DEA Schedule CV

Strength

100 mg/1

Manufacturer

UCB, Inc.

NDC

50474077066

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

BRIVARACETAM

Approval Type

New Drug (NDA)

FDA Application

NDA205836

FDA Approved

5/12/2016

TE Code

AB

On Market Since

5/12/2016

Pharmacological Classes

Epoxide Hydrolase Inhibitors

Price Statistics

The NADAC for BRIVIACT 100 MG TABLET has been published 479 times since Jun 21, 2017, and over the history we have for it it has risen 51.3%. The table below summarizes its recorded NADAC range and movement.

Current price$24.0762 per EA
All-time high$24.1004 (May 13, 2026)
All-time low$15.9102 (Jun 21, 2017)
52-week high$24.1004
52-week low$23.4824
Median price$20.7723
Average price$20.3516
Largest weekly change+7.0% (Jan 10, 2018)
Weeks tracked479
Tracking sinceJun 21, 2017

Price History

1W

+0.0%

1M

+0.0%

3M

-0.0%

6M

-0.1%

1Y

+2.5%

3Y

+9.4%

5Y

+23.9%

All

+51.3%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of BRIVIACT 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BRIVIACT 100 MG TABLET, manufactured by UCB, Inc., is $24.0762 per EA (NDC 50474077066), effective Aug 19, 2026.

How has the price of BRIVIACT 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for BRIVIACT 100 MG TABLET has risen 51.3%. It has been tracked across 479 weekly CMS publications since Jun 21, 2017.

What are the highest and lowest recorded NADAC prices for BRIVIACT 100 MG TABLET?

Since Jun 21, 2017, the NADAC for BRIVIACT 100 MG TABLET has ranged from a low of $15.9102 (Jun 21, 2017) to a high of $24.1004 (May 13, 2026), with a median of $20.7723 per EA.

Are there cheaper alternatives to BRIVIACT 100 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BRIVIACT 100 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures BRIVIACT 100 MG TABLET?

BRIVIACT 100 MG TABLET (NDC 50474077066) is labeled by UCB, Inc., and CMS classifies it as a brand product.